Safety evaluation of Phytovagex, a pessary formulation of Nigella sativa, on pregnant rats

Document Type : Short communication

Authors

1 Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences

2 Pharmacological Research Center of Medicinal Plants, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

3 Student Research Committee, Mashhad University of Medical Sciences

4 Neurogenic Inflammation Research Centre, Department of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Abstract


Objective: The possible toxicity of drugs in pregnancy should be tested before their use in pregnant patients. In the present study, we aimed to evaluate the safety of phytovagex, a pessary formulation of Nigella sativa (N. sativa), which is already in clinical use for vaginal fungal infection.
Materials and Methods: The pregnant rats were treated intravaginal with physiological saline (vehicle) or phytovagex pessary in the first half of their pregnancy (days 1 to 10 of gestation). Duration of pregnancy and health parameters of the newborns were recorded after parturition. Also, cytotoxicity of N. sativa hydroalcoholic extract was tested against ovary Cho cells. 
Results: The phytovagex had no significant effect on the duration of pregnancy, number of newborns, weight of neonates, and percent of stillbirth. No deformity or general behavioral abnormality was observed in neonates monitored for 30 days after birth. N. sativa extract had no significant effect on the viability of ovary cells at the concentrations of 12.5-200 µg/mL.
Conclusion: Results of this animal study showed that phytovagex has no overall effect on the duration of pregnancy and health parameters of the newborns. Also, its active agent, N. sativa, does not induce any cytotoxic effect on ovary cells.

Keywords

Main Subjects

References

AbuKhader MM, Khater SH, Al-Matubsi HY. 2013. Acute effects of thymoquinone on the pregnant rat and embryo-fetal development. Drug Chem Toxicol, 36: 27-34.
Al-Enazi MM. 2007. Effect of thymoquinone on malformations and oxidative stress-induced diabetic mice. Pak J Biol Sci, 10: 3115-3119.
Alinejad B, Ghorbani A, Sadeghnia HR. 2013. Effects of combinations of curcumin, linalool, rutin, safranal, and thymoquinone on glucose/serum deprivation-induced cell death. Avicenna J Phytomed, 3: 321-328.
Babazadeh B, Sadeghnia HR, Kapurchal ES, Parsaee H, Nasri S Tayarani-Najaran Z. 2012. Protective effect of Nigella sativa and thymoquinone on serum/glucose deprivation-induced DNA damage in PC12 cells. Avicenna J Phytomed, 2: 125-132.
Calixto JB. 2000. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res, 33: 179-189.
De Santis M, Straface G, Carducci B, Cavaliere AF, De Santis L, Lucchese A, Merola AM, Caruso A. 2004. Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol, 117: 10-19.
De Smet PAGM. 2004. Health risks of herbal remedies: an update. Clin Pharmacol Ther, 76: 1-17.
Dollah MA, Parhizkar S, Izwan M. 2013. Effect of Nigella sativa on the kidney function in rats. Avicenna J Phytomed, 3: 152-158.
Forouzanfar F, Fazly BSB, Hosseinzadeh H. 2015. Black cumin (Nigella sativa) and its constituent (thymoquinone): A review on antimicrobial effects. Iran J Basic Med Sci, 17: 929-938.
Ghorbani A, Asadpour E, Sadeghnia HR. 2015. Mechanism of protective effect of lettuce against glucose/serum deprivation-induced neurotoxicity. Nutr Neurosci, 18: 103-109.
Ghorbani A, Hadjzadeh MR, Rajaei Z, Zendehbad SB. 2014. Effects of fenugreek seeds on adipogenesis and lipolysis in normal and diabetic rat. Pak J Biol Sci, 17: 523-528.
Ghorbani A. 2013a. Best herbs for managing diabetes: a review of clinical studies. Braz J Pharm Sci, 49: 413-422.
Ghorbani A. 2013b. Phytotherapy for diabetic dyslipidemia: evidence from clinical trials. Clin Lipidol, 8: 311-319.
Goel G, Makkar HP, Francis G, Becker K. 2007. Phorbol esters: structure, biological activity, and toxicity in animals. Int J Toxicol, 26: 279-88.
Hadi V, Kheirouri S, Alizadeh M, Khabbazi A, Hosseini H. 2015. Effects of Nigella sativa oil extract on inflammatory cytokine response and oxidative stress status in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Avicenna J Phytomed, in press.
Hosseini A, GhorbaniA. 2015. Cancer therapy with phytochemicals: evidence from clinical studies. Avicenna J Phytomed, 5: 84-97.
Jordan SA, Cunningham DG, Marles RJ. 2010. Assessment of herbal medicinal products: challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol Appl Pharmacol. 243: 198-216.
Keshri G, Singh M, Lakshmi V, Kamboj V. 1995. Post-coital contraceptive efficacy of the seeds of Nigella sativa in rats. Indian J physiol pharmacol, 39: 59-62.
Korgun ET, Dohr G, Desoye G, Demir R, Kayisli UA, Hahn T. 2003. Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction, 125: 75-84.
Mollazadeh H, Hosseinzadeh H. 2014. The protective effect of Nigella Sativa against liver injury: a review. Iran J Basic Med Sci, 17: 958-966.
Nickavar B, Mojab F, Javidnia K, Amoli MR. 2003. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C, 58: 629-631.
Oliaee D, Boroushaki MT, Oliaee N, Ghorbani A. 2014. Evaluation of cytotoxicity and antifertility effects of Artemisia Kopetdaghensis. Adv Pharmacol Sci, 2014: 745760.
Peters P, Miller RK, Schaefer C. Drugs during pregnancy and lactation: treatment options and risk assessment. Schaefer C, Peters PWJ, Miller RK (eds). 3rd edition. 2015. Elsevier. San Diego, CA, USA. pp. 1-21.
Rakhshandeh H, Vahdati-Mashhadian N, khajekaramadini M. 2011. In vitro and in vivo study of the antibacterial effects of Nigella sativa methanol extract in dairy cow mastitis. Avicenna J Phytomed, 1: 29-35.
Shafiee-Nick R, Ghorbani A, Vafaee F, Rakhshandeh H. 2012. Chronic administration of a combination of six herbs inhibits the progression of hyperglycemia and decreases serum lipids and aspartate amino transferase activity in diabetic rats. Adv Pharmacol Sci, 2012, 789796.
Shafiq H, Ahmad A, Masud T, Kaleem M. 2014. Cardio-protective and anti-cancer therapeutic potential of Nigella sativa. Iran J Basic Med Sci, 17: 967-979.
Sun F, Akazawa S, Sugahara K, Kamihira S, Kawasaki E, Eguchi K, Koji T. 2002. Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and Bcl-2. Arch Histol Cytol, 65: 145-157.
Vahdati-Mashhadian N, Rakhshandeh H, Omidi A. 2005. An investigation on LD50 and subacute hepatic toxicity of Nigella sativa seed extracts in mice. Pharmazie, 60: 544-547.
Wan Ezumi MF, Amrah SS, Suhaimi A, Mohsin S. 2007. Evaluation of the female reproductive toxicity of aqueous extract of Labisia pumila var. alata in rats. Indian J Pharmacol, 39: 30-32.
Xia HF1, Cao JL, Jin XH, Ma X. 2013. MiR199a is implicated in embryo implantation by regulating Grb10 in rat. Reproduction, 147: 91-99.
Yadav S, Agarwal M. 2011. Effect of Nigella sativa on the estrous cycle and ovarian activity in albino rats. Pharmacologyonline, 3: 997-1006.
Avicenna Journal of Phytomedicine
Volume 6, Issue 1 - Serial Number 1
January and February 2016
Pages 117-123

Files

Share

How to cite

Statistics